ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 274 filers reported holding ARRAY BIOPHARMA INC in Q1 2019. The put-call ratio across all filers is 0.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $2,345,000 | +161.7% | 50,612 | +37.7% | 0.05% | +170.0% |
| Q1 2019 | $896,000 | +71.0% | 36,744 | 0.0% | 0.02% | +53.8% |
| Q4 2018 | $524,000 | -57.5% | 36,744 | -54.7% | 0.01% | -51.9% |
| Q3 2018 | $1,232,000 | -9.4% | 81,070 | 0.0% | 0.03% | -15.6% |
| Q2 2018 | $1,360,000 | +55.3% | 81,070 | +51.0% | 0.03% | +52.4% |
| Q1 2018 | $876,000 | +27.5% | 53,693 | 0.0% | 0.02% | +31.2% |
| Q4 2017 | $687,000 | +24.9% | 53,693 | +20.1% | 0.02% | +33.3% |
| Q3 2017 | $550,000 | – | 44,706 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Advisory Services Network, LLC | 3,442 | $159,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |